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Cytotoxic lymphocytes, encompassing cytotoxic T cells and nat-
ural killer (NK) cells, play a pivotal role in immune defense. By
directed release of perforin-containing lytic granules, cytotoxic
lymphocytes can eradicate pathogen-infected, tumorigenic, and
otherwise stressed cells. By the virtue of cytokine and chemokine
secretion, they can also influence other cells of the immune system.
In addition, cytotoxic lymphocytes can kill activated immune cells
to limit excessive immune reactions and maintain homeostasis.
In recent years, much progress has been made with respect to the
mechanisms by which cytotoxic lymphocytes develop, differenti-
ate, and exert their effector functions. In this Research Topic, we
collected several exciting articles that highlight the mechanisms
controlling the development and effector function of cytotoxic
lymphocytes, as well as the role these cells play in several disease
conditions.
We open the Research Topic with a review providing an up-to-
date view on the development and differentiation of NK cells, and
their relationships to other innate lymphoid cells. The authors
describe in detail NK cell developmental progression through
distinct stages before reaching the mature phenotype, and dis-
cuss possible reasons behind functional and phenotypic plasticity
among NK cells from different tissues (1). With respect to differ-
entiation, NK cells receive cues from several other cell types. Of
particular interest is the ability of NK cells and dendritic cells to
influence each other’s function during early immune responses.
Such reciprocal interactions are the focus of a fascinating review
by Chijioke and Munz (2).
Next, we take a closer look at series of molecular events shap-
ing the response of cytotoxic lymphocytes. A research article by
Olofsson et al. (3) demonstrates how stimulation by IL-2 influ-
ences the migration of individual NK cells and their recognition
and killing of target cells. Then, a review by Galandrini et al.
(4) discusses the mechanisms underlying activation of cytolytic
machinery following target cell recognition. Two complementary
reviews focus on the maturation and release of lytic granules,
and the high-resolution techniques that allow for visualization
of lytic granules and quantification of their subsequent fusion
with the plasma membrane at the contact site with target cells
(5, 6). The following research article shows how inhibitory signals
interrupt the formation of activating synapses formed by primary
NK cells, thus disrupting NK cell cytotoxicity (7). Finally, Baginska
et al. (8) present a fascinating view from the opposite, target cell
side, providing us with a comprehensive review of how tumor
cells can affect the function of NK cells and evade cell death;
these include secretion of multiple tumor-derived immunosup-
pressive factors and metabolites,or autophagy-mediated resistance
to NK-mediated killing.
In a clinical perspective, a wide variety of mutations impair-
ing cytotoxic lymphocyte development and/or function have been
associated with severe diseases in humans. Impaired activity of
cytotoxic lymphocytes has been linked to an increased suscep-
tibility to viral infections, persistent inflammation, cancer, and
autoimmunity. In the middle part of our Research Topic, we gath-
ered articles that describe defects in cytotoxic lymphocyte biology
and their relation to different human disease conditions. Focusing
on NK cells, Ham and Billadeau (9) summarize a variety of human
immunodeficiency syndromes that affect lymphocyte cytotoxi-
city, bridging the molecular, and clinical side of this Research
Topic. A Hypothesis and Theory article introduces the interest-
ing concept of “perforinopathy” (10). The authors discuss how
immune dysregulation and immunopathology are caused by, or
related to decreased perforin activity and/or delivery to the target
cells, and present compelling evidence that this may be more com-
mon cause of human disease than previously assumed. Sieni et al.
(11) provide an extensive view of hemophagocytic lymphohisti-
ocytosis, an immunodeficiency caused by defective lymphocyte
cytotoxicity, and describe how the knowledge gained by character-
ization of patients with hemophagocytic syndromes contributes
to our understanding of cytotoxic lymphocyte function. This in-
depth review is followed by two outstanding papers that illustrate
the effect of mutations affecting cytotoxic lymphocyte activity
in hemophagocytic lymphohistiocytosis. Jessen et al. (12) com-
pare different molecular defects in lytic granule-associated lytic
pathway with the clinical phenotype of hemophagocytic lym-
phohistiocytosis; based on the degree of impairment of cytotoxic
lymphocyte activity a gradient of disease manifestations is distin-
guished, both in human hemophagocytic lymphohistiocytosis and
the mouse models of the disorders. Muller et al. (13) characterize a
novel missense mutation in syntaxin-11, and demonstrate that this
mutation abrogates binding between syntaxin-11 and Munc18-2,
www.frontiersin.org June 2014 | Volume 5 | Article 279 | 1
Krzewski and Bryceson Cytotoxic lymphocytes and human diseases
an interaction critical for release of lytic granules from cytotoxic
lymphocytes. Thus, the authors identify an important mechanism
that could underlay the development of the familial hemophago-
cytic lymphohistiocytosis. The last article in this part of the
Research Topic focuses on CD57 molecule in NK cell function,
its expression pattern during NK cell differentiation and, impor-
tantly, in several pathologies, such as cancer, autoimmunity, and
infections. The review compiles our current knowledge about
the role of CD57 as a marker for NK cell function and disease
association (14).
Lymphocyte cytotoxic activity may be harnessed therapeuti-
cally to target tumor cells in different adoptive cellular therapy
regimes or through the use of recombinant antibodies. In this
regard, Mentlik James et al. (15) describe and discuss differ-
ent therapies available to enhance NK cell anti-tumor responses,
with a particular focus on the use of a variety of therapeutic
antibodies and immuno-modulating drugs to fight hematologic
malignancies. Della Chiesa et al. (16) review the response of NK
cells to human cytomegalovirus. The authors summarize evi-
dence for how cytomegalovirus infection can promote NK cell
development and maturation, which could actually be benefi-
cial for the hematopoietic stem cell transplant therapies, due to
accelerated anti-leukemic or even anti-viral responses. In addi-
tion, the aforementioned review by Chijioke and Munz (2) high-
lights the potential therapeutic benefits of dendritic cell–NK cell
interactions, from enhancing anti-tumor NK cell responses, to
dendritic cell-mediated expansion of tumor-specific T cells, to
decreasing graft-versus-host-disease in different transplantation
settings.
We hope that the reader will find this Research Topic very
interesting and informative. We invite you to read the following
articles and immerse yourself in the fascinating world of cytotoxic
lymphocytes and their function.
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